Page last updated: 2024-10-19

pyruvaldehyde and Heart Disease, Ischemic

pyruvaldehyde has been researched along with Heart Disease, Ischemic in 2 studies

Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.

Research Excerpts

ExcerptRelevanceReference
"Pyridoxamine treatment decreased glycation and restored the activation of JNK and Akt during ischemia."1.39Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia. ( Almeida, F; Crisóstomo, J; Gonçalves, L; Matafome, P; Rodrigues, T; Santos-Silva, D; Seiça, R; Sena, C, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crisóstomo, J2
Matafome, P2
Santos-Silva, D2
Rodrigues, L1
Sena, CM1
Pereira, P1
Seiça, R2
Almeida, F1
Rodrigues, T1
Sena, C1
Gonçalves, L1

Other Studies

2 other studies available for pyruvaldehyde and Heart Disease, Ischemic

ArticleYear
Methylglyoxal chronic administration promotes diabetes-like cardiac ischaemia disease in Wistar normal rats.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:12

    Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Heart; Male; Myocar

2013
Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:6

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Glycation End Products, Advanced; JNK

2013